SCHEDULE 13G: Jorey Chernett Discloses 9.99% Stake in Kazia Therapeutics Through Schedule 13G Filing
Beneficial Ownership Report
Jorey Chernett has reported a beneficial ownership of 9.99% of Kazia Therapeutics Ltd.'s American Depositary Shares, as detailed in a recent Schedule 13G filing with the SEC.
Summary
- Jorey Chernett has filed a Schedule 13G with the U.S. Securities and Exchange Commission, indicating beneficial ownership in KAZIA THERAPEUTICS LTD.
- The filing reports that Jorey Chernett beneficially owns 137,200 American Depositary Shares of KAZIA THERAPEUTICS LTD.
- This ownership stake represents 9.99% of the total class of American Depositary Shares.
- Jorey Chernett holds sole voting power and sole dispositive power over all 137,200 shares.
- The shares were certified as not acquired or held for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having that purpose or effect, other than activities solely in connection with a nomination under Rule 240.14a-11.
Sentiment
Score: 5
Explanation: Neutral, as this is a factual disclosure of beneficial ownership and does not contain performance, strategic, or forward-looking information.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of beneficial ownership and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant individual shareholder's stake in the company.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of event which requires filing of this statement |
| 06/12/2025 | Date of signature for the Schedule 13G filing |
Keywords
KAZIA THERAPEUTICS LTD, American Depositary Shares, ADS, Schedule 13G, Beneficial Ownership, Jorey Chernett, Equity Stake, Shareholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.